201 related articles for article (PubMed ID: 31419624)
1. Bifunctional chemical probes inducing protein-protein interactions.
Maniaci C; Ciulli A
Curr Opin Chem Biol; 2019 Oct; 52():145-156. PubMed ID: 31419624
[TBL] [Abstract][Full Text] [Related]
2. PROTACs: An Emerging Therapeutic Modality in Precision Medicine.
Nalawansha DA; Crews CM
Cell Chem Biol; 2020 Aug; 27(8):998-1014. PubMed ID: 32795419
[TBL] [Abstract][Full Text] [Related]
3. Small molecule PROTACs in targeted therapy: An emerging strategy to induce protein degradation.
Xi M; Chen Y; Yang H; Xu H; Du K; Wu C; Xu Y; Deng L; Luo X; Yu L; Wu Y; Gao X; Cai T; Chen B; Shen R; Sun H
Eur J Med Chem; 2019 Jul; 174():159-180. PubMed ID: 31035238
[TBL] [Abstract][Full Text] [Related]
4. Proteolysis-targeting chimeras for targeting protein for degradation.
Qi J; Zhang G
Future Med Chem; 2019 Apr; 11(7):723-741. PubMed ID: 30706727
[TBL] [Abstract][Full Text] [Related]
5. HaloPROTACS: Use of Small Molecule PROTACs to Induce Degradation of HaloTag Fusion Proteins.
Buckley DL; Raina K; Darricarrere N; Hines J; Gustafson JL; Smith IE; Miah AH; Harling JD; Crews CM
ACS Chem Biol; 2015 Aug; 10(8):1831-7. PubMed ID: 26070106
[TBL] [Abstract][Full Text] [Related]
6. PROTACs: An Emerging Targeting Technique for Protein Degradation in Drug Discovery.
Gu S; Cui D; Chen X; Xiong X; Zhao Y
Bioessays; 2018 Apr; 40(4):e1700247. PubMed ID: 29473971
[TBL] [Abstract][Full Text] [Related]
7. Targeted protein degradation via intramolecular bivalent glues.
Hsia O; Hinterndorfer M; Cowan AD; Iso K; Ishida T; Sundaramoorthy R; Nakasone MA; Imrichova H; Schätz C; Rukavina A; Husnjak K; Wegner M; Correa-Sáez A; Craigon C; Casement R; Maniaci C; Testa A; Kaulich M; Dikic I; Winter GE; Ciulli A
Nature; 2024 Mar; 627(8002):204-211. PubMed ID: 38383787
[TBL] [Abstract][Full Text] [Related]
8. Biophysical and Computational Approaches to Study Ternary Complexes: A 'Cooperative Relationship' to Rationalize Targeted Protein Degradation.
Ward JA; Perez-Lopez C; Mayor-Ruiz C
Chembiochem; 2023 May; 24(10):e202300163. PubMed ID: 37018140
[TBL] [Abstract][Full Text] [Related]
9. PROTACs- a game-changing technology.
Konstantinidou M; Li J; Zhang B; Wang Z; Shaabani S; Ter Brake F; Essa K; Dömling A
Expert Opin Drug Discov; 2019 Dec; 14(12):1255-1268. PubMed ID: 31538491
[No Abstract] [Full Text] [Related]
10. Comparative analysis of biophysical methods for monitoring protein proximity induction in the development of small molecule degraders.
Przytulski K; Glaza P; Brach K; Sagan M; Statkiewicz G; Klajn J; Walczak MJ
Biochim Biophys Acta Gen Subj; 2023 Sep; 1867(9):130398. PubMed ID: 37301332
[TBL] [Abstract][Full Text] [Related]
11. The Present and Future of Novel Protein Degradation Technology.
Xia L; Liu W; Song Y; Zhu H; Duan Y
Curr Top Med Chem; 2019; 19(20):1784-1788. PubMed ID: 31644408
[TBL] [Abstract][Full Text] [Related]
12. Design and Applications of Bifunctional Small Molecules: Why Two Heads Are Better Than One.
Corson TW; Aberle N; Crews CM
ACS Chem Biol; 2008 Nov; 3(11):677-692. PubMed ID: 19112665
[TBL] [Abstract][Full Text] [Related]
13. Native Mass Spectrometry: Insights and Opportunities for Targeted Protein Degradation.
Sternicki LM; Poulsen SA
Anal Chem; 2023 Dec; 95(51):18655-18666. PubMed ID: 38090751
[TBL] [Abstract][Full Text] [Related]
14. Development of targeted protein degradation therapeutics.
Chamberlain PP; Hamann LG
Nat Chem Biol; 2019 Oct; 15(10):937-944. PubMed ID: 31527835
[TBL] [Abstract][Full Text] [Related]
15. Bifunctional modalities for repurposing protein function.
Modell AE; Lai S; Nguyen TM; Choudhary A
Cell Chem Biol; 2021 Jul; 28(7):1081-1089. PubMed ID: 34270935
[TBL] [Abstract][Full Text] [Related]
16. A suite of mathematical solutions to describe ternary complex formation and their application to targeted protein degradation by heterobifunctional ligands.
Han B
J Biol Chem; 2020 Nov; 295(45):15280-15291. PubMed ID: 32859748
[TBL] [Abstract][Full Text] [Related]
17. New strategy for renal fibrosis: Targeting Smad3 proteins for ubiquitination and degradation.
Wang X; Feng S; Fan J; Li X; Wen Q; Luo N
Biochem Pharmacol; 2016 Sep; 116():200-9. PubMed ID: 27473774
[TBL] [Abstract][Full Text] [Related]
18. Chasing molecular glue degraders: screening approaches.
Domostegui A; Nieto-Barrado L; Perez-Lopez C; Mayor-Ruiz C
Chem Soc Rev; 2022 Jul; 51(13):5498-5517. PubMed ID: 35723413
[TBL] [Abstract][Full Text] [Related]
19. Lessons in PROTAC Design from Selective Degradation with a Promiscuous Warhead.
Bondeson DP; Smith BE; Burslem GM; Buhimschi AD; Hines J; Jaime-Figueroa S; Wang J; Hamman BD; Ishchenko A; Crews CM
Cell Chem Biol; 2018 Jan; 25(1):78-87.e5. PubMed ID: 29129718
[TBL] [Abstract][Full Text] [Related]
20. Differential PROTAC substrate specificity dictated by orientation of recruited E3 ligase.
Smith BE; Wang SL; Jaime-Figueroa S; Harbin A; Wang J; Hamman BD; Crews CM
Nat Commun; 2019 Jan; 10(1):131. PubMed ID: 30631068
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
